CRISPR for Disease-990x200.png

Register Now

Already registered?
Access the webinar here »

Protein Metrics Webinar Sign Up (12th Sept 2018)

You must have Javascript and Cookies enabled to access this webcast.

Webinar Summary

This webinar explores the technology behind Mammoth Biosciences’ newly announced CRISPR-powered diagnostics platform, giving insight to CRISPR and how it works for disease detection.

In this webinar, Ashley will first give an explanation of what CRISPR does and how it’s been used up until this point. From there, she will dive into the ways in which CRISPR can be leveraged for disease detection, and how CRISPR can be used to democratize sample analysis in everything from healthcare to agriculture.

In addition, she will also give an overview of her own recently-launched company, Mammoth Biosciences, a biotech company that has developed the world’s first and only CRISPR-enabled detection platform capable of sensing any biomarker or disease with DNA/RNA.

Viewers will walk away with:
  • A better understanding of CRISPR technology, how it works, and how it has been used up until this point
  • A strong grasp on the potential for CRISPR technology for disease detection, and how it could increase medical accessibility in places struggling to find healthcare
  • An in-depth look at how CRISPR technology is poised to make dramatic advancements across a variety of industries, from healthcare to agriculture to livestock to even oil and gas
  • An inside look at Mammoth’s first-of-its-kind platform (co-founded by CRISPR pioneer Jennifer Doudna)

Speaker Information:

Ashley Tehranchi
Ashley Tehranchi
Co-founder and CTO,
Mammoth Biosciences